BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32029260)

  • 1. Optical Coherence Tomography Assessment for Percutaneous Coronary Intervention of the Left Main Artery: The IDEAL-LM Trial.
    Chang CC; Onuma Y; Lesiak M; Merkulov E; Anderson R; Kretov E; Barragan P; Oldroyd KG; van Geuns RJ
    JACC Cardiovasc Interv; 2020 Feb; 13(3):401-402. PubMed ID: 32029260
    [No Abstract]   [Full Text] [Related]  

  • 2. Serial OCT Imaging in Vascular Healing After Everolimus-Eluting Stent Implantation.
    Yano H; Horinaka S; Ishimitsu T
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):147-148. PubMed ID: 28528155
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of Early Healing Profile and Neointimal Transformation Over 24 Months Using Longitudinal Sequential Optical Coherence Tomography Assessments and 3-Year Clinical Results of the New Dual-Therapy Endothelial Progenitor Cell Capturing Sirolimus-Eluting Combo Stent: The EGO-Combo Study.
    Lee SW; Lam SC; Tam FC; Chan KK; Shea CP; Kong SL; Wong AY; Yung A; Zhang LW; Tse HF; Wu KK; Chan R; Haude M; Mehran R; Mintz GS; Maehara A
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27418609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migrated remnant bioresorbable scaffolds in a left main bifurcation lesion: Insights from optical coherence tomography.
    Seo J; Kim Y; Kim BK; Hong SJ; Ahn CM; Kim JS; Cho DK; Ko YG; Choi D; Hong MK; Jang Y
    Cardiol J; 2020; 27(2):208-209. PubMed ID: 32463107
    [No Abstract]   [Full Text] [Related]  

  • 5. Marking Technique for Identification of Optimal Stent Landing Site With Optical Coherence Tomographic Imaging.
    Nakamura Y; Kataoka Y; Asaumi Y; Noguchi T; Yasuda S
    JACC Cardiovasc Interv; 2018 May; 11(10):e79-e80. PubMed ID: 29730368
    [No Abstract]   [Full Text] [Related]  

  • 6. Temporal course of vessel healing and neoatherosclerosis after DES implantation.
    Kozuki A; Shinke T; Otake H; Shite J; Nakagawa M; Nagoshi R; Hariki H; Inoue T; Osue T; Taniguchi Y; Nishio R; Hirata KI
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1121-1123. PubMed ID: 24135328
    [No Abstract]   [Full Text] [Related]  

  • 7. A recurrent coronary honeycomb-like structure: insights from angioscopy and optical coherence tomography.
    Seike F; Kawakami H; Oshita A; Matsuoka H
    Coron Artery Dis; 2016 Jun; 27(4):331-3. PubMed ID: 26807622
    [No Abstract]   [Full Text] [Related]  

  • 8. Early healing assessment with optical coherence tomography of everolimus-eluting stents with bioabsorbable polymer (synergy™) at 3 and 6 months after implantation.
    de la Torre Hernández JM; Tejedor P; Camarero TG; Duran JM; Lee DH; Monedero J; Laso FS; Calderón MA; Veiga G; Zueco J
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):E67-73. PubMed ID: 26526783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial assessment of bioresorbable-polymer sirolimus-eluting stent by coronary angioscopy and optical coherence tomography.
    Nakamura S; Kimura S; Nakagama S; Hayashi Y; Yamamoto T; Utsugi Y; Doi J; Mizusawa M; Araki M; Sudo Y; Hishikari K; Hikita H; Takahashi A; Isobe M
    Coron Artery Dis; 2017 Sep; 28(6):530-531. PubMed ID: 28402989
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictors for Clinical Outcome of Untreated Stent Edge Dissections as Detected by Optical Coherence Tomography.
    van Zandvoort LJC; Tomaniak M; Tovar Forero MN; Masdjedi K; Visseren L; Witberg K; Ligthart J; Kardys I; Lemmert ME; Diletti R; Wilschut J; de Jaegere P; Zijlstra F; Van Mieghem NM; Daemen J
    Circ Cardiovasc Interv; 2020 Mar; 13(3):e008685. PubMed ID: 32089001
    [No Abstract]   [Full Text] [Related]  

  • 11. Serial Assessment of Strut Coverage of Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months After Stent Implantation by Optical Frequency Domain Imaging: The DISCOVERY 1TO3 Study (Evaluation With OFDI of Strut Coverage of Terumo New Drug Eluting Stent With Biodegradable Polymer at 1, 2, and 3 Months).
    Chevalier B; Smits PC; Carrié D; Mehilli J; Van Boven AJ; Regar E; Sawaya FJ; Chamié D; Kraaijeveld AO; Hovasse T; Vlachojannis GJ
    Circ Cardiovasc Interv; 2017 Dec; 10(12):. PubMed ID: 29246909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular Fibrillation Associated With Coronary Plaque Erosion Detected by Optical Coherence Tomography.
    Yasumura K; Patel NJ; Vengrenyuk Y; Kini AS; Baber U
    JACC Cardiovasc Interv; 2020 Jan; 13(1):e5-e7. PubMed ID: 31838109
    [No Abstract]   [Full Text] [Related]  

  • 13. Morphological, Functional, and Biological Vascular Healing Response 6 Months After Drug-Eluting Stent Implantation: A Randomized Comparison of Three Drug-Eluting Stents.
    Nakata T; Fujii K; Fukunaga M; Shibuya M; Kawai K; Kawasaki D; Naito Y; Ohyanagi M; Masuyama T
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):350-7. PubMed ID: 26526816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected Measurement Error in Optical Coherence Tomography-Guided Percutaneous Coronary Intervention.
    Katamine M; Minami Y; Yanagisawa T; Meguro K; Shimohama T; Tojo T; Ako J
    JACC Cardiovasc Interv; 2018 Nov; 11(21):e179-e180. PubMed ID: 30343016
    [No Abstract]   [Full Text] [Related]  

  • 15. Early Follow-Up Optical Coherence Tomographic Findings of Significant Drug-Eluting Stent Malapposition.
    Lee SY; Ahn CM; Yoon HJ; Hur SH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2018 Dec; 11(12):e007192. PubMed ID: 30562088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overtime evaluation of the vascular HEALing process after everolimus-eluting stent implantation by optical coherence tomography. The HEAL-EES study.
    Otsuki S; Brugaletta S; Sabaté M; Shiratori Y; Gomez-Monterrosas O; Scalone G; Romero-Villafañe S; Hernández-Enríquez M; Freixa X; Martín-Yuste V; Masotti M
    Cardiovasc Revasc Med; 2016 Jun; 17(4):241-7. PubMed ID: 27158001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomography and intravascular ultrasound of double kissing crush coronary bifurcation stenting.
    McGeoch RJ; Tanaka K; Kotowycz MA; Bezerra HG; Džavík V
    EuroIntervention; 2014 Jul; 10(3):338. PubMed ID: 24862341
    [No Abstract]   [Full Text] [Related]  

  • 19. Fate of Different Types of Intrastent Tissue Protrusion: Optical Coherence Tomography and Angioscopic Serial Observations at Baseline and 9-Day and 3-Month Follow-Up.
    Suzuki S; Nakatani S; Sotomi Y; Shiojima I; Sakata Y; Higuchi Y
    JACC Cardiovasc Interv; 2018 Jan; 11(1):95-97. PubMed ID: 29248411
    [No Abstract]   [Full Text] [Related]  

  • 20. Neointimal tissue characterization after implantation of drug-eluting stents by optical coherence tomography: quantitative analysis of optical density.
    Nishino S; Sakuma M; Kanaya T; Nasuno T; Tokura M; Toyoda S; Abe S; Nakamura D; Tanaka K; Attizzani GF; Bezerra HG; Costa MA; Inoue T
    Int J Cardiovasc Imaging; 2019 Nov; 35(11):1971-1978. PubMed ID: 31218524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.